Eyenuk Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Employees
  • 26

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $26.9M

  • Investors
  • 9

Eyenuk General Information

Description

Developer of an artificial intelligence eye screening technology designed for autonomous disease detection, risk assessment, and disease surveillance. The company's technology provides automated diabetic retinopathy screening without the need for expert human grading or eye dilation and analyzes patients' retinal images acquired using an integrated fundus camera, enabling patients to screen their eyes to ensure timely diagnosis of life- and vision-threatening diseases.

Contact Information

Website
www.eyenuk.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 5850 Canoga Avenue
  • Suite 250
  • Woodland Hills, CA 91367
  • United States
+1 (818)
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Vertical(s)
Artificial Intelligence & Machine Learning, HealthTech
Corporate Office
  • 5850 Canoga Avenue
  • Suite 250
  • Woodland Hills, CA 91367
  • United States
+1 (818)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Eyenuk Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
14. Later Stage VC (Series A) 23-Aug-2022 $26.9M Completed Generating Revenue
13. Grant 01-Jul-2020 Completed Generating Revenue
12. Grant 30-Sep-2019 Completed Generating Revenue
11. Grant 01-Jun-2018 Completed Generating Revenue
10. Grant 01-Jun-2018 Completed Generating Revenue
9. Seed Round 30-Apr-2018 Completed Generating Revenue
8. Seed Round 31-Oct-2017 Completed Clinical Trials - General
7. Grant 01-Aug-2016 Completed Clinical Trials - General
6. Seed Round 19-Jul-2016 $1.5M $1.5M Completed Clinical Trials - General
5. Grant 01-Jan-2016 $7M Completed Product In Beta Test
To view Eyenuk’s complete valuation and funding history, request access »

Eyenuk Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A-2
Series A-1
Series S-2
Series S-1 289,276 $0.000100 6% $5.37 $5.37 1x $5.37 3.23%
Series S 348,547 $0.000100 6% $4.49 $4.49 1x $4.49 3.89%
To view Eyenuk’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Eyenuk Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an artificial intelligence eye screening technology designed for autonomous disease detection, risk assessm
Diagnostic Equipment
Woodland Hills, CA
26 As of 2025

Pensacola, FL
 

Coralville, IA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Eyenuk Competitors (9)

One of Eyenuk’s 9 competitors is IRIS (Diagnostic Equipment), a Venture Capital-Backed company based in Pensacola, FL.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
IRIS (Diagnostic Equipment) Venture Capital-Backed Pensacola, FL
Digital Diagnostics Venture Capital-Backed Coralville, IA
VisionQuest Biomedical Accelerator/Incubator Backed Albuquerque, NM
Icare (Diagnostic Equipment) Formerly VC-backed Vantaa, Finland
Notal Vision Venture Capital-Backed Manassas, VA
You’re viewing 5 of 9 competitors. Get the full list »

Eyenuk Patents

  • 28

    Total Documents Applications and Grants

  • Total Patents Families

  • 12

    Granted

  • 4

    Pending

  • Expiring in next 12 mo

Eyenuk Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220079436-A1 Systems and apparatuses for three-dimensional eye imaging for screening, monitoring, and diagnosis of diseases Pending 17-Sep-2020
US-20220075509-A1 Graphical element detection using a combined series and delayed parallel execution unified target technique, a default graphical element detection technique, or both Active 08-Sep-2020
US-11281362-B1 Graphical element detection using a combined series and delayed parallel execution unified target technique, a default graphical element detection technique, or both Active 08-Sep-2020
US-20210353141-A1 Systems, methods, and apparatuses for eye imaging, screening, monitoring, and diagnosis Active 26-Nov-2018
US-12239378-B2 Systems, methods, and apparatuses for eye imaging, screening, monitoring, and diagnosis Active 26-Nov-2018 A61B3/12
To view Eyenuk’s complete patent history, request access »

Eyenuk Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Eyenuk Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
A&C Foelsgaard Alternativer Venture Capital Minority
AXA Investment Managers Asset Manager Minority
Kendall Capital Partners Venture Capital Minority
KOFA Healthcare Venture Capital Minority
T&W Medical Family Office Minority
You’re viewing 5 of 9 investors. Get the full list »

Ready to get started?

Request a free trial

Eyenuk FAQs

  • When was Eyenuk founded?

    Eyenuk was founded in 2010.

  • Where is Eyenuk headquartered?

    Eyenuk is headquartered in Woodland Hills, CA.

  • What is the size of Eyenuk?

    Eyenuk has 26 total employees.

  • What industry is Eyenuk in?

    Eyenuk’s primary industry is Diagnostic Equipment.

  • Is Eyenuk a private or public company?

    Eyenuk is a Private company.

  • What is the current valuation of Eyenuk?

    The current valuation of Eyenuk is .

  • What is Eyenuk’s current revenue?

    The current revenue for Eyenuk is .

  • How much funding has Eyenuk raised over time?

    Eyenuk has raised $33M.

  • Who are Eyenuk’s investors?

    A&C Foelsgaard Alternativer, AXA Investment Managers, Kendall Capital Partners, KOFA Healthcare, and T&W Medical are 5 of 9 investors who have invested in Eyenuk.

  • Who are Eyenuk’s competitors?

    IRIS (Diagnostic Equipment), Digital Diagnostics, VisionQuest Biomedical, Icare (Diagnostic Equipment), and Notal Vision are some of the 9 competitors of Eyenuk.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »